Effective treatment against ESBL-producing klebsiella pneumoniae through synergism of the photodynamic activity of Re (I) compounds with beta-lactams
Date Issued
2021-11
Author(s) USM
Dreyse, Paulina
DOI
10.3390/pharmaceutics13111889
Abstract
Background: Extended-spectrum beta-lactamase (ESBL) and carbapenemase (KPC+) producing Klebsiella pneumoniae are multidrug-resistant bacteria (MDR) with the highest risk to human health. The significant reduction of new antibiotics development can be over
Política de Privacidad 
